ArticleNational journal of maxillofacial surgery
Comparative evaluation of spirulina and lycopene as an adjuvant to intralesional corticosteroid injection therapy in the management of oral submucous fibrosis: A pilot study.
Article in National journal of maxillofacial surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oral submucous fibrosis (OSMF) is a chronic, progressive condition characterized by fibrosis of the oral mucosa, leading to restricted mouth opening and significant impairment in quality of life. Current treatment modalities lack a universally accepted protocol, prompting the need for adjunctive therapies to enhance treatment outcomes. Objective: To compare the efficacy of spirulina and lycopene as antioxidant adjuvants to intralesional corticosteroid therapy in the management of OSMF. Materials and Methods: A prospective, double-blinded, randomized controlled trial was conducted with 30 participants diagnosed with Grade III OSMF. Patients were randomly assigned to two groups: Group I received spirulina 500 mg tablets daily, and Group II received lycopene 8 mg tablets daily. Both groups received weekly intralesional corticosteroid injections (Triamcinolone Acetonide 40 mg/ml) for 8 weeks. Clinical parameters, including mouth opening, burning sensation, recurrent ulceration, cheek flexibility, and the presence of fibrous bands, were assessed at baseline and at 3- and 6-month follow-ups. Results: Spirulina demonstrated a statistically significant improvement in mouth opening (33.60 ± 3.20 mm) compared to lycopene (30.73 ± 3.05 mm) ( Conclusion: Spirulina, due to its potent antioxidant and anti-inflammatory properties, is a more effective adjuvant to corticosteroid therapy in the management of OSMF compared to lycopene. Future research with larger, more diverse populations is warranted to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.